Author Archives: Sibyl Wilmont

About Sibyl Wilmont

Sibyl Wilmont is a second-career registered nurse and clinical researcher with more than 25 years of experience in health care journalism, patient advocacy, pharmaceutical/biotech PR, and academic medical communications.

Medical ethicist discusses Right-to-Try legislation

Photo: Marko Javorac via Flickr

Taken at face value, Right-to-Try (RTT) legislation sounds like a no-brainer, promising to improve access to treatments yet unapproved for marketing by the FDA for people with terminal illnesses. But it’s not that simple, according to Alison Bateman-House, Ph.D., M.P.H., M.A., an ethicist and assistant professor at the New York University School of Medicine.

In fact, many of its basic provisions make it unlikely to deliver on its promise. At a New York City Metro AHCJ Chapter meeting in November, she discussed reasons for her argument that RTT will only serve to limit, rather than expand, access to potentially life-saving treatments. Continue reading